Incipiam Pharma focuses on developing innovative treatments for metabolic diseases by targeting energy expenditure.
Incipiam Pharma has raised $526K in total funding. The most recent round was Pre-Seed. The last funding was announced in February 2025.
Incipiam Pharma's investors include BioInnovation Institute Venture Lab.
Incipiam Pharma is headquartered in Copenhagen, Denmark.
Incipiam Pharma focuses on developing innovative treatments for metabolic diseases by targeting energy expenditure.
Incipiam Pharma is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Incipiam Pharma — Funding & Investors." VCBacked, February 25, 2025, https://www.vcbacked.co/company/incipiam-pharma. Accessed August 14, 2026.
VCBacked. (2025). Incipiam Pharma — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/incipiam-pharma
{{cite web |title=Incipiam Pharma — Funding & Investors |url=https://www.vcbacked.co/company/incipiam-pharma |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated